Cite
APA Citation
Huhn, G. D., Tebas, P., Gallant, J., Wilkin, T., Cheng, A., Yan, M., Zhong, L., Callebaut, C., Custodio, J. M., Fordyce, M. W., Das, M., & McCallister, S. (2017). a Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. Journal of acquired immune deficiency syndromes, 74, . http://access.bl.uk/ark:/81055/vdc_100052536085.0x000001